Correction: Promising efficacy of teniposide in H3K27M mutant diffuse midline gliomas: a case report
Frontiers in Oncology · 11.05.2026 · 16
DOI: 10.3389/fonc.2026.1868322 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Oncology, online erschienen am 11.05.2026. Verfasst von Xiaoman Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College of Jinan University, Department of Radiotherapy, Shenzhen People's Hospital, Shenzhen, Guangdong, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Clinical Medical College of Jinan University, Department of Radiotherapy, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
- The Second Clinical Medical College of Jinan University, Department of Pharmacy, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
- Departments of Pathology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
Zitieren
APA
Wang, X., Niu, T., Xia, J., Liu, J., & Sun, M. (2026). Correction: Promising efficacy of teniposide in H3K27M mutant diffuse midline gliomas: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1868322
Vancouver
Wang X, Niu T, Xia J, Liu J, Sun M. Correction: Promising efficacy of teniposide in H3K27M mutant diffuse midline gliomas: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1868322
BibTeX
@article{Wang2026,
author = {Wang, Xiaoman and Niu, Tingting and Xia, Junxian and Liu, Jing and Sun, Mengqi},
title = {Correction: Promising efficacy of teniposide in H3K27M mutant diffuse midline gliomas: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1868322}
}
EUVIMED